Harnessing the Microbiome to Advance Precision Medicine & Transform Therapeutics for IBD
Time: 2:00 pm
day: Day One
Details:
- How can biopharma leverage microbiome-targeted treatments to reduce inflammation?
- Using biomarkers to stratify populations for microbiome-targeted therapeutics
- Advancing therapeutic development using microbiome-modifying strategies
- Leveraging microbiome signatures to enhance patient response to therapies
